Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disease of the Newborn”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT06024876
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia

Who this might be right for
Beta-Thalassemia
CorrectSequence Therapeutics Co., Ltd 5
Not applicableStudy completedNCT00789516
What this trial is testing

The Change of Coagulation Markers in Children With β-thalassemia Disease After Stem Cell Transplantation

Who this might be right for
Thalassemia
Mahidol University 60
Early research (Phase 1)Study completedNCT04260516
What this trial is testing

The Effect of N-acetylcysteine on Oxidative Stress Status and Iron Overload in Thalassemia Major

Who this might be right for
Thalassemia Major
Beni-Suef University 100
Not applicableStudy completedNCT00011648
What this trial is testing

Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia

Who this might be right for
Pulmonary HypertensionSickle Cell AnemiaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 986
Not applicableStudy completedNCT00736060
What this trial is testing

Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever

Who this might be right for
Sickle Cell AnemiaSickle Cell Thalassemia
HaEmek Medical Center, Israel 60
Not applicableStudy completedNCT02729363
What this trial is testing

The Feasibility of the PAINReportIt Guided Relaxation Intervention-Outpatient

Who this might be right for
Sickle Cell DiseaseStressPain
University of Florida 30
Not applicableStudy completedNCT01058473
What this trial is testing

Psychometric Evaluation of the IPPAQ in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain

Who this might be right for
Sickle Cell DiseasePain
Connecticut Children's Medical Center 159
Testing effectiveness (Phase 2)Study completedNCT02140554
What this trial is testing

A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Genetix Biotherapeutics Inc. 54
Not applicableLooking for participantsNCT06941389
What this trial is testing

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease (SCD)
University of Rochester 480
Not applicableStudy completedNCT07207551
What this trial is testing

Prevalence of Hemoglobinopathies Associated With Significant Hb Variants in the Chattogram Region of Bangladesh

Who this might be right for
Hemoglobinopathies
Bangladesh Bioscience Research Group 760
Testing effectiveness (Phase 2)Study completedNCT00445978
What this trial is testing

The Effects of 6R-BH4 in Subjects With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
BioMarin Pharmaceutical 32
Not applicableActive Not RecruitingNCT04406818
What this trial is testing

Metabolic and Hemodynamic Reserve in Pediatric SCA

Who this might be right for
Child, OnlyBrain DiseasesSickle Cell Disease+1 more
Washington University School of Medicine 120
Testing effectiveness (Phase 2)WithdrawnNCT01948817
What this trial is testing

Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses

Who this might be right for
Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
Novartis Pharmaceuticals
Very early researchLooking for participantsNCT06565026
What this trial is testing

CS-206 in Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
CorrectSequence Therapeutics Co., Ltd 5
Not applicableStudy completedNCT04121247
What this trial is testing

Nonpharmacological Approaches and Parental Education in Children With Sickle Cell Disease

Who this might be right for
Nursing Caries
Akdeniz University 163
Testing effectiveness (Phase 2)Active Not RecruitingNCT04853576
What this trial is testing

A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)

Who this might be right for
Sickle Cell DiseaseHemoglobinopathies
Editas Medicine, Inc. 45
Very early researchWithdrawnNCT04776850
What this trial is testing

Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies

Who this might be right for
Beta Thalassemia MajorSickle Beta 0 ThalassemiaSickle Beta Plus Thalassemia+3 more
M.D. Anderson Cancer Center
Not applicableTemporarily pausedNCT05442346
What this trial is testing

Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells

Who this might be right for
Thalassemia Major
Bioray Laboratories 5
Not applicableStudy completedNCT03621826
What this trial is testing

Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease

Who this might be right for
Stroke IschemicSickle Cell Disease
Medical University of South Carolina 5,247
Testing effectiveness (Phase 2)Study completedNCT01749540
What this trial is testing

Study to Evaluate the Safety and Efficacy of Luspatercept (ACE-536) in Participants With Beta-thalassemia (A536-04/MK-6143-002)

Who this might be right for
B-Thalassemia
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 64
Next Page